Andrzej Adam Mackiewicz
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Immunology 62
- Immunotherapy and Immune Responses 33
- Oncology 69
- CAR-T cell therapy research 26
- Cancer Immunotherapy and Biomarkers 19
- Co-authors
- Waldemar Ratajczak (2 shared papers)Stefan Rose‐John (12 shared papers)Heidi Schooltink (2 shared papers)Hanna Dams‐Kozlowska (26 shared papers)Irving Kushner (8 shared papers)Peter Claus Heinrich (7 shared papers)Mariusz Kaczmarek (11 shared papers)Heinz Baumann (2 shared papers)
- Journals
- International Journal of Molecular Sciences (9 papers)Advances in experimental medicine and biology (7 papers)Expert Opinion on Biological Therapy (6 papers)Cancers (6 papers)The Lancet Oncology (5 papers)
- Partner nations
- PolandUnited StatesGermany
In The Last Decade
Andrzej Adam Mackiewicz
214 papers receiving 20.1k citations
Andrzej Adam Mackiewicz's Hit Papers
Peers
Comparison fields: 5 of 211
- Oncology 8.0k
- Cancer Research 2.5k
- Immunology 3.6k
- Molecular Biology 8.6k
- Gastroenterology 505
Countries citing papers authored by Andrzej Adam Mackiewicz
This map shows the geographic impact of Andrzej Adam Mackiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Adam Mackiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Adam Mackiewicz more than expected).
Fields of papers citing papers by Andrzej Adam Mackiewicz
This network shows the impact of papers produced by Andrzej Adam Mackiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Adam Mackiewicz. The network helps show where Andrzej Adam Mackiewicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrzej Adam Mackiewicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive molecular characterization of gastric adenocarcinoma Hit paper breakdown → | 2014 | 5209 |
| 2 | Genomic Classification of Cutaneous Melanoma Hit paper breakdown → | 2015 | 2509 |
| 3 | Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib Hit paper breakdown → | 2014 | 2163 |
| 4 | Principal components analysis (PCA) Hit paper breakdown → | 1993 | 1097 |
| 5 | Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma Hit paper breakdown → | 2019 | 1048 |
| 6 | 1993 | 459 | |
| 7 | 2017 | 423 | |
| 8 | Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance Hit paper breakdown → | 2021 | 370 |
| 9 | 1992 | 334 | |
| 10 | 2014 | 325 | |
| 11 | Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial Hit paper breakdown → | 2021 | 296 |
| 12 | Acute Phase Proteins Molecular Biology, Biochemistry, and Clinical Applications | 1993 | 265 |
| 13 | 2015 | 220 | |
| 14 | 2020 | 204 | |
| 15 | 2018 | 181 | |
| 16 | 2004 | 174 | |
| 17 | Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review Hit paper breakdown → | 2023 | 167 |
| 18 | 2017 | 148 | |
| 19 | 1981 | 144 | |
| 20 | 2015 | 143 |
About Andrzej Adam Mackiewicz
Andrzej Adam Mackiewicz is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Genetics, having authored 223 papers that have together received 20.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (33 papers), CAR-T cell therapy research (26 papers), Melanoma and MAPK Pathways (21 papers), Cancer Immunotherapy and Biomarkers (19 papers), Virus-based gene therapy research (18 papers), Silk-based biomaterials and applications (17 papers), Glycosylation and Glycoproteins Research (15 papers) and RNA Interference and Gene Delivery (14 papers). The work is most often cited by research in Oncology (8.0k citations), Cancer Research (2.5k citations), Immunology (3.6k citations), Molecular Biology (8.6k citations) and Gastroenterology (505 citations). Andrzej Adam Mackiewicz has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Waldemar Ratajczak, Stefan Rose‐John, Heidi Schooltink, Hanna Dams‐Kozlowska, Irving Kushner, Peter Claus Heinrich, Mariusz Kaczmarek, Heinz Baumann, Anna Florczak and Jacek Mackiewicz. Their work appears in journals such as International Journal of Molecular Sciences, Advances in experimental medicine and biology, Expert Opinion on Biological Therapy, Cancers and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.